0001209191-20-048900.txt : 20200901 0001209191-20-048900.hdr.sgml : 20200901 20200901160534 ACCESSION NUMBER: 0001209191-20-048900 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200827 FILED AS OF DATE: 20200901 DATE AS OF CHANGE: 20200901 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIMARD JOHN CENTRAL INDEX KEY: 0001639078 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37347 FILM NUMBER: 201154518 MAIL ADDRESS: STREET 1: 8201 E RIVERSIDE DRIVE STREET 2: BLDG 4, STE 100 CITY: AUSTIN STATE: TX ZIP: 78744 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: XBiotech Inc. CENTRAL INDEX KEY: 0001626878 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 BUSINESS PHONE: 512-386-2930 MAIL ADDRESS: STREET 1: 8201 E. RIVERSIDE DRIVE STREET 2: BUILDING 4, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78744 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-08-27 0 0001626878 XBiotech Inc. XBIT 0001639078 SIMARD JOHN 5217 WINNEBAGO LANE AUSTIN TX 78744 1 1 1 0 Chief Executive Officer Stock Option 18.25 2020-08-27 4 A 0 25000 0.00 A 2021-02-27 2030-08-27 Common Stock 25000 25000 D On August 27, 2020 (the Grant Date) the reporting person was granted nonstatutory stock options (the Options) under the Company's 2015 Equity Incentive Plan to purchase shares of the Company's Common Stock (the Shares) at an exercise price equal to the closing sales price of the Shares on the Grant Date as quoted by the Nasdaq Stock Market. The Options vest in two equal portions at six month and one year from the Grant Date with an expiry of ten years from the Grant Date. /s/ Ashley Otero under Power of Attorney for John Simard 2020-09-01